KPC-Kp,Vaborbactam:

Mario Tumbarello1,2, Francesca Raffaelli3, Maddalena Giannella4

  • 1Department of Medical Biotechnologies, University of Siena, Siena, Italy.

PubMed
概括

梅罗-瓦博巴克坦有效治疗产生KPC的Klebsiella pneumoniae感染,包括对其他药物耐药的感染. 在48小时内提前服用可改善严重病例的存活率.